Stay updated on Niraparib & Pembrolizumab in TNBC & Ovarian Cancer Clinical Trial
Sign up to get notified when there's something new on the Niraparib & Pembrolizumab in TNBC & Ovarian Cancer Clinical Trial page.

Latest updates to the Niraparib & Pembrolizumab in TNBC & Ovarian Cancer Clinical Trial page
- Check2 days agoChange DetectedThe page revision tag changed from v3.6.0 to v3.6.2, indicating a new page build. This likely represents maintenance or a small fix to the study details page rather than a content update.SummaryDifference0.0%

- Check9 days agoNo Change Detected
- Check17 days agoChange DetectedThe study record page now includes new navigation/help sections such as 'How to Read a Study Record', 'Common Questions', and 'How to Join a Study', and the heading for 'Intervention/Treatment' has replaced the old 'Intervention / Treatment' label with a new 'Revision: v3.6.0'. It also displays 'No longer looking for participants', indicating the study is not currently enrolling.SummaryDifference0.3%

- Check24 days agoChange DetectedThe revision label in the study documents area was updated from v3.5.4 to v3.5.5, indicating a newer version of the document.SummaryDifference0.0%

- Check45 days agoChange DetectedRevision: v3.5.4 has been added and Revision: v3.5.3 has been removed, indicating a small update to the page's revision metadata. This is a routine maintenance change and does not alter the study details or other substantive content on the page.SummaryDifference0.0%

- Check67 days agoChange DetectedThe page’s footer software/version label was updated from “Revision: v3.5.2” to “Revision: v3.5.3,” indicating a non-content site update.SummaryDifference0.0%

- Check74 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

Stay in the know with updates to Niraparib & Pembrolizumab in TNBC & Ovarian Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Niraparib & Pembrolizumab in TNBC & Ovarian Cancer Clinical Trial page.